Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from COPD

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

Benzinga

Study finds singing these three songs could help treat lung disease

Researchers may have found a safe and effective treatment for chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)

The Independent UK

Singing songs by Elvis and The Beatles can help lung patients – study

A new study saw patients given singing therapy in group sessions online.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland)

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Merck said Wednesday it would buy COPD drugmaker Verona Pharma for $10 billion. The news sent Verona stock flying.

Investors Business Daily

Is Sylvester Stallone Dead? Not The Actor But The Funk Frontman Sly Stone: Cause Of Death And What We Know

Sly Stone, funk legend and frontman of Sly and the Family Stone, died at 82 from COPD complications. Actor Sylvester Stallone is alive despite online confusion.

International Business Times UK

“A monumental figure, a groundbreaking innovator, and a true pioneer who redefined the landscape of pop, funk, and rock music”: Sly Stone, restlessly creative musical giant who led Sly and the Family Stone, dies at 82

The visionary multi-instrumentalist, singer, and songwriter had been battling COPD, according to his family

Guitar World

Read news from The Economist, FT, and more,
with one subscription

Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure

Regeneron stock crashed Friday after the company's Sanofi-partnered COPD treatment unexpectedly failed in a Phase 3 study.

Investors Business Daily

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Tuesday's Stock Of The Day is testing a buy point after Verona Pharma broke out last week on blowout sales for its COPD treatment.

Investors Business Daily

Lung disease test done by AI to be rolled out in GP surgeries

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The Independent UK

‘Game-changing’ AI-driven lung test set for GP surgery rollout

The device, known as N-Tidal Diagnose, uses carbon dioxide sensors to measure changes in a patient’s lung function with results given in minutes.

Evening Standard

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

MarketBeat

David Lynch death: What are the symptoms and causes of emphysema?

The biggest risk is smoking

The Independent UK

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

UK Using AI To Cut Patient Hospital Visits

The government in the United Kingdom is using artificial intelligence (AI) in the healthcare industry to cut down on hospital visits, having already seen a 40% reduction in the number of COPD patients.

The Conversation

First new treatment for asthma and COPD in half a century – new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

Medical Daily

New Treatment For Asthma, COPD Flare-Ups: Single Dose Of Existing Antibody Injection May Cut Hospitalizations

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

Evening Standard

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'

The injection is the first new treatment for asthma and COPD attacks in 50 years

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Benralizumab: London scientists create 'game-changing' first treatment for asthma attacks in 50 years

Researchers say injection will be ‘game changing’ for people with the respiratory condition

The Guardian - UK

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

The Independent UK

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells

Evening Standard

First treatment in 50 years for serious asthma attacks is ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

Medical Daily

Study Finds Daily Dose Of Vitamin B3 Reduces Inflammation In COPD Patients

The study suggests that taking vitamin B3 could reduce lung inflammatory biomarkers by up to 63%.

The Independent UK

What is COPD and what are the symptoms?

Every winter, GP surgeries and hospitals see an increase in visits from people with respiratory conditions.

Evening Standard

AI urine analysis predicts infection in lung disease patients a week in advance

The technology could help personalise treatment and prevent hospitalisations, academics said.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.